Entity information:

 

NOTE 15 – INCOME TAXES

 

The provision (benefit) for income taxes for the years ended December 31, 2016 and 2015 consist of the following:

 

 

2016

 

2015

Federal:

 

 

 

 

 

  Current

$

0

 

$

0

  Deferred

 

(26,093)

 

 

548,820

State:

 

 

 

 

 

  Current

 

0

 

 

0

  Deferred

 

(807)

 

 

1,700

Valuation allowance

 

26,900

 

 

(550,520)

Total

$

0

 

$

0

 

Net deferred tax assets consist of the following components as of December 31, 2016 and 2015:

 

 

2016

 

2015

Deferred tax assets (liabilities):

 

 

 

 

 

 

 

 

 

 

 

    NOL Carryover

$

2,359,051

 

$

2,233,958

    Stock Based Compensation

 

158,854

 

 

89,485

    Depreciation and Amortization

 

 (355,962)

 

 

 (184,846)

Inventory Reserves

 

(3,800)

 

 

(7,354)

    R&D Tax Credits

 

(39,667)

 

 

(39,667)

    Debenture Interest Payable

 

(474,381)

 

 

(474,381)

    Other Reserves

 

19,884

 

 

19,884

    Valuation Allowance

 

(1,663,979)

 

$

(1,637,079)

    Net deferred tax asset (liability)

$

0

 

 

0

 

The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2016 and 2015 due to the following:

 

 

2016

 

2015

Tax at statutory rate

$

(75,669)

 

$

292,578

Effects of:

 

 

 

 

 

   Debenture write-off

 

0

 

 

225,019

   Meals and Entertainment

 

(3,506)

 

 

0

   Stock Based Compensation

 

(69,369)

 

 

(89,485)

   Depreciation and Amortization

 

125,853

 

 

115,054

   Inventory Reserve

 

(3,553)

 

 

7,354

   Other, net

 

(656)

 

 

0

   Change in Valuation Allowance

 

26,900

 

$

(550,520)

Total

$

0

 

 

0

 

At December 31, 2016, the Company had net operating loss carryforwards of approximately $6,740,147 that may be offset against future income from the year 2016 through 2036. 

 

No tax benefit has been reported in the December 31, 2016 consolidated financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.

 

The valuation allowance increased by $26,900 to $1,663,979 as of December 31, 2016.